m.Stock by Mirae AssetOpen Demat Account
m.Stock by Mirae Asset

IPO Akums Drugs & Pharmaceuticals Ltd

  • Price Range

    ₹646 - ₹679

  • Min. Quantity

    22

  • Closes on

    1 August 2024

  • Min. investment

    ₹14,938/286 Shares

Akums Drugs & Pharmaceuticals Ltd IPO Timeline

Akums Drugs and Pharmaceuticals Limited was incorporated vide Certificate of Incorporation dated April 19, 2004 and received a Certificate for Commencement of Business dated May 13, 2004 issued by the RoC.

EventDate
Akums Drugs & Pharmaceuticals Ltd IPO Opening Date30 July 2024
Akums Drugs & Pharmaceuticals Ltd IPO Closing Date 1 August 2024
Basis of Allotment2 August 2024
Initiation of Refunds5 August 2024
Credit of Shares to Demat5 August 2024
Akums Drugs & Pharmaceuticals Ltd IPO Listing Date6 August 2024

Akums Drugs & Pharmaceuticals Ltd IPO Details

Akums Drugs & Pharmaceuticals Ltd IPO Date30 July 2024 to 1 August 2024
Akums Drugs & Pharmaceuticals Ltd IPO Face Value2 per share
Akums Drugs & Pharmaceuticals Ltd IPO Price646 to ₹679 per share
Akums Drugs & Pharmaceuticals Ltd IPO Lot Size22
Issue SizeShares of ₹2 (aggregating up to ₹1,856.74 Cr)
Fresh IssueShares of ₹2 (aggregating up to ₹680 Cr)
Offer for SaleShares of ₹2 (aggregating up to ₹1,176.74 Cr)
Issue Type(Book Built Portion)
Listing At BSE, NSE
QIB Shares OfferedNot more than 81,37,276 of the Net Offer
Retail Shares OfferedNot less than 27,12,424 of the Net Offer
NII (HNI) Shares OfferedNot less than 40,68,637 of the Net Offer
Company PromotersSanjeev Jain, Sandeep Jain, Akums Master Trust

Akums Drugs & Pharmaceuticals Ltd IPO Lot Size

The Akums Drugs & Pharmaceuticals Ltd IPO lot size is 22 shares. A retail-individual investor can apply for up to 13 lots (286 shares or ₹1,94,194).

Application LotsSharesAmount
Minimum122₹14,938
Maximum13286₹1,94,194
  • Risks
  • Opportunities
  • Largest India-focused CDMO serving the Indian domestic pharmaceutical industry.
  • Diverse client base with longstanding CDMO relationships.
  • Large and rapidly growing R&D capabilities across its product portfolio.
  • Strategic presence across the pharmaceutical value chain.
  • Experienced and entrepreneurial management team with a proven track record and marquee healthcare focused PE investor.

Company Financials

Akums Drugs & Pharmaceuticals Ltd Financial Information (Restated)

Period Ended Total AssetsTotal RevenueProfit After Tax
03-20242,095.431,538.24-165.45
03-20231,894.211,382.98125.43
03-20221,813.951,220.54-381.77
Amount in ₹ Crore

Objects of the Issue

The company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:

  • Repayment/prepayment of all or certain borrowings of the company and subsidiary
  • Funding incremental working capital requirements of the company
  • Pursuing inorganic growth initiatives through acquisitions
  • General corporate purposes

Akums Drugs & Pharmaceuticals Ltd IPO Promoter Holding

Pre Issue Share Holding19.43%
Post Issue Share Holding17.23%

Akums Drugs & Pharmaceuticals Ltd IPO Subscription Status (Bidding Detail)

The Akums Drugs & Pharmaceuticals Ltd IPO is subscribed 63.56 times on 1 August 2024 05:00:00 PM. The public issue subscribed 21.3 times in the retail category, 90.09 times in the QIB category, and 42.21 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategoryQIBNIIRetailEmployeeTotal
Subscription (times)90.0942.2121.34.2763.56

Akums Drugs & Pharmaceuticals Ltd IPO Prospectus

Akums Drugs & Pharmaceuticals Ltd IPO Listing Date

Listing Date6 August 2024
BSE Script 544222
NSE SymbolAKUMS
Listing In BSE, NSE
ISININE09XN01023
IPO Price679
Face Value2

Company Contact Information

Akums Drugs & Pharmaceuticals Ltd
304 Mohan Place LSC SaraswatiVihar,Delhi-110034
Phone: +91 11 6904 1000
Email: cs@akums.net
Website: www.akums.in

Akums Drugs & Pharmaceuticals Ltd IPO Registrar

Phone:+91 810 811 4949
Email: akumsdrugs.ipo@linkintime.co.in
Website: www.linkintime.co.in

Akums Drugs & Pharmaceuticals Ltd IPO Lead Manager(s)

  1. ICICI Securities Ltd
  2. Axis Capital Ltd
  3. Citigroup Global Markets India Pvt Ltd
  4. Ambit Pvt Ltd

FAQ

What is the issue size of Akums Drugs & Pharmaceuticals Ltd IPO?

Akums Drugs & Pharmaceuticals Ltd IPO, which opens for subscription from to 1 August 2024 has an issue size of ₹1,856.74 crore. The issue type is book building issue.

I have pre-applied for Akums Drugs & Pharmaceuticals Ltd IPO. When will my order get placed?

In case of pre-apply, your IPO order will be placed on the Exchange as soon as the official bidding for TBI Corn Ltd IPO begins. You will receive a UPI request within 24 hours after the bidding period opens.

What are the open and close dates for Akums Drugs & Pharmaceuticals Ltd IPO?

Akums Drugs & Pharmaceuticals Ltd IPO Opens for subscription from 30 July 2024 to 1 August 2024

What is the lot size and minimum order quantity of the Akums Drugs & Pharmaceuticals Ltd IPO?

The lot size of Akums Drugs & Pharmaceuticals Ltd is 22 shares. Retail investors can subscribe to minimum 1 lot and maximum 13 lots. The minimum and maximum application value is ₹14,938 and ₹1,94,194 respectively.

What are the allotment dates for the Akums Drugs & Pharmaceuticals Ltd IPO?

Allotment date for Akums Drugs & Pharmaceuticals Ltd is 2 August 2024 and refund of application amount (in case allotment is not received) will begin from 5 August 2024. If your allotment goes through, then shares will be credited in your Demat account by 5 August 2024.

Who is the registrar of Akums Drugs & Pharmaceuticals Ltd IPO?

The registrar for Akums Drugs & Pharmaceuticals Ltd IPO is MUFG Intime India Pvt Ltd. You can check your IPO allotment status on the registrar's website.

Where is the Akums Drugs & Pharmaceuticals Ltd IPO getting listed?

The shares of Akums Drugs & Pharmaceuticals Ltd are proposed to be listed on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE)